Catalyst Wire Dossier Catalyst Wire Dossier

Pregabalin Immediate Release Capsule

pregabalin · Yuhan Corporation
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Pregabalin Immediate Release Capsule, covering 2023-10-23 to 2023-10-23. Get the full timeline:

Most recent: Clinical Trial Update: A Randomized, Active-controlled, Parallel, Open-label, Multicenter, Phase 4 Study to Compare the Efficacy and Safety of Pregabalin Sustained Release Tablet and Pregabalin Immediate Release Capsule in Type II Diabetic Patients With Peripheral Neuropathic Pain [Phase 4]

See pricing